These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 21169793)

  • 21. Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal rats.
    Kivell BM; Day DJ; McDonald FJ; Miller JH
    Brain Res Dev Brain Res; 2004 Mar; 149(1):9-19. PubMed ID: 15013624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical fentanyl in a randomized, double-blind study in patients with corneal damage.
    Zöllner C; Mousa S; Klinger A; Förster M; Schäfer M
    Clin J Pain; 2008 Oct; 24(8):690-6. PubMed ID: 18806534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphatidylinositol-3 kinase is distinctively required for mu-, but not kappa-opioid receptor-induced activation of c-Jun N-terminal kinase.
    Kam AY; Chan AS; Wong YH
    J Neurochem; 2004 Apr; 89(2):391-402. PubMed ID: 15056283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The p75 receptor is associated with inflammatory thermal hypersensitivity.
    Watanabe T; Ito T; Inoue G; Ohtori S; Kitajo K; Doya H; Takahashi K; Yamashita T
    J Neurosci Res; 2008 Dec; 86(16):3566-74. PubMed ID: 18709654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heat hyperalgesia induced by endoneurial nerve growth factor and the expression of substance P in primary sensory neurons.
    Ruiz G; Baños JE
    Int J Neurosci; 2009; 119(2):185-203. PubMed ID: 19125373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC; Purohit V; Patel K; Zhang Q
    Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy.
    Mousa SA; Shaqura M; Khalefa BI; Zöllner C; Schaad L; Schneider J; Shippenberg TS; Richter JF; Hellweg R; Shakibaei M; Schäfer M
    Diabetes; 2013 Apr; 62(4):1308-19. PubMed ID: 23230081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase C-mediated mu-opioid receptor phosphorylation and desensitization in rats, and its prevention during early diabetes.
    Mousa SA; Shaqura M; Winkler J; Khalefa BI; Al-Madol MA; Shakibaei M; Schulz S; Schäfer M
    Pain; 2016 Apr; 157(4):910-921. PubMed ID: 26713421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p38 mitogen-activated protein kinase and PI3-kinase are involved in up-regulation of mu opioid receptor transcription induced by cycloheximide.
    Kim DK; Hwang CK; Wagley Y; Law PY; Wei LN; Loh HH
    J Neurochem; 2011 Mar; 116(6):1077-87. PubMed ID: 21198637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin-nerve preparation to assay the function of opioid receptors in peripheral endings of sensory neurons.
    Moshourab R; Schmidt Y; Machelska H
    Methods Mol Biol; 2015; 1230():215-28. PubMed ID: 25293328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid system in depression.
    Matussek N
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):443. PubMed ID: 14604460
    [No Abstract]   [Full Text] [Related]  

  • 33. Interference of pain control employing opioids in in vivo immunological experiments.
    Piersma FE; Daemen MA; Bogaard AE; Buurman WA
    Lab Anim; 1999 Oct; 33(4):328-33. PubMed ID: 10778781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Senescence of endplate osteoclasts induces sensory innervation and spinal pain.
    Pan D; Benkato KG; Han X; Zheng J; Kumar V; Wan M; Zheng J; Cao X
    Elife; 2024 Jun; 12():. PubMed ID: 38896465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role.
    Naser PV; Kuner R
    Neuron; 2018 Sep; 99(6):1102-1104. PubMed ID: 30236278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation.
    Xing J; Kornhauser JM; Xia Z; Thiele EA; Greenberg ME
    Mol Cell Biol; 1998 Apr; 18(4):1946-55. PubMed ID: 9528766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Nerve Growth Factor in Orofacial Pain.
    Mai L; Huang F; Zhu X; He H; Fan W
    J Pain Res; 2020; 13():1875-1882. PubMed ID: 32801845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-Arrestin 2 and ERK1/2 Are Important Mediators Engaged in Close Cooperation between TRPV1 and µ-Opioid Receptors in the Plasma Membrane.
    Melkes B; Markova V; Hejnova L; Novotny J
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electroacupuncture attenuates spinal nerve ligation-induced microglial activation mediated by p38 mitogen-activated protein kinase.
    Liang Y; Du JY; Qiu YJ; Fang JF; Liu J; Fang JQ
    Chin J Integr Med; 2016 Sep; 22(9):704-13. PubMed ID: 25847774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of c-Jun NH2-terminal kinase stimulates mu opioid receptor expression via p38 MAPK-mediated nuclear NF-κB activation in neuronal and non-neuronal cells.
    Wagley Y; Hwang CK; Lin HY; Kam AF; Law PY; Loh HH; Wei LN
    Biochim Biophys Acta; 2013 Jun; 1833(6):1476-88. PubMed ID: 23485395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.